12 results on '"Wulaningsih, Wahyu"'
Search Results
2. Cancer rehabilitation: closing the gap in low- and middle-income countries.
- Author
-
Anwar SL, Adistyawan G, Wulaningsih W, Erlangga Z, Gutenbrunner C, and Nugraha B
- Subjects
- Developing Countries, Female, Humans, Income, Male, Needs Assessment, Neoplasms diagnosis, Global Health, Neoplasms rehabilitation, Poverty
- Published
- 2019
- Full Text
- View/download PDF
3. Rehabilitation for Cancer Survivors: How We Can Reduce the Healthcare Service Inequality in Low- and Middle-Income Countries.
- Author
-
Anwar SL, Adistyawan G, Wulaningsih W, Gutenbrunner C, and Nugraha B
- Subjects
- Cancer Survivors psychology, Developing Countries, Humans, Neoplasms psychology, Physical and Rehabilitation Medicine standards, Quality of Life, Socioeconomic Factors, Healthcare Disparities statistics & numerical data, Neoplasms rehabilitation, Physical and Rehabilitation Medicine methods, Quality of Health Care
- Abstract
Cancer diagnosis often substantially affects patient's physical, psychological, and emotional status. Most patients with cancer experience declining of energy, activity levels, social-cultural participation, and relationships. In addition, cancer progression and adverse effects of aggressive cancer treatment often cause debilitating pain, fatigue, weakness, joint stiffness, depression, emotional instability, limited mobility, poor nutritional status, skin breakdown, bowel dysfunction, swallowing difficulty, and lymphedema leading into functional impairment and disability that can be addressed through rehabilitation care. Comprehensive care models by involving cancer rehabilitation have resulted in significant improvement of patient's quality of life. Although cancer rehabilitation has been implemented in many high-income countries, it is either not yet or suboptimally delivered in most low- and middle-income countries. In this review, we discussed gaps regarding cancer rehabilitation services and identified opportunities to improve quality of cancer care in developing countries. Future collaborations among international organizations and stakeholders of health care delivery systems are required to initiate and improve high-quality cancer rehabilitation in the developing countries.
- Published
- 2018
- Full Text
- View/download PDF
4. Steer cancer funding to align with clinical goals.
- Author
-
Watkins J and Wulaningsih W
- Subjects
- Humans, Goals, Neoplasms
- Published
- 2018
- Full Text
- View/download PDF
5. Circulating uric acid levels and subsequent development of cancer in 493,281 individuals: findings from the AMORIS Study.
- Author
-
Yiu A, Van Hemelrijck M, Garmo H, Holmberg L, Malmström H, Lambe M, Hammar N, Walldius G, Jungner I, and Wulaningsih W
- Subjects
- Female, Follow-Up Studies, Humans, Incidence, Male, Neoplasms mortality, Proportional Hazards Models, Social Class, Sweden epidemiology, Neoplasms blood, Neoplasms epidemiology, Population Surveillance, Uric Acid blood
- Abstract
Objectives: Serum uric acid has been suggested to be associated with cancer risk. We aimed to study the association between serum uric acid and cancer incidence in a large Swedish cohort., Results: A positive association was found between uric acid levels and overall cancer risk, and results were similar with adjustment for glucose, triglycerides and BMI. Hazard ratio (HR) for overall cancer for the 4th quartile of uric acid compared to the 1st was 1.08 (95% CI: 1.05-1.11) in men and 1.12 (1.09 - 1.16) in women. Site-specific analysis showed a positive association between uric acid and risk of colorectal, hepatobiliary, kidney, non-melanoma skin, and other cancers in men and of head and neck and other cancers in women. An inverse association was observed for pulmonary and central nervous system (CNS) cancers in men and breast, lymphatic and haematological, and CNS malignancies in women., Materials and Methods: We included 493,281 persons aged 20 years and older who had a measurement of serum uric acid and were cancer-free at baseline in the AMORIS study. Multivariable Cox proportional hazards regression was used to investigate sex-specific quartiles of serum uric acid in relation to cancer risk in men and women. Analysis was further adjusted for serum glucose, triglycerides and, where available, BMI. Site-specific analysis was performed for major cancers., Conclusions: Altered uric acid levels were associated with risk of overall and some specific cancers, further indicating the potential role of uric acid metabolism in carcinogenesis.
- Published
- 2017
- Full Text
- View/download PDF
6. Transposable Elements in Human Cancer: Causes and Consequences of Deregulation.
- Author
-
Anwar SL, Wulaningsih W, and Lehmann U
- Subjects
- Genomic Instability, Humans, Oncogene Proteins genetics, Oncogene Proteins metabolism, RNA, Untranslated genetics, Tumor Suppressor Proteins genetics, Tumor Suppressor Proteins metabolism, DNA Transposable Elements, Gene Expression Regulation, Neoplastic, Neoplasms genetics
- Abstract
Transposable elements (TEs) comprise nearly half of the human genome and play an essential role in the maintenance of genomic stability, chromosomal architecture, and transcriptional regulation. TEs are repetitive sequences consisting of RNA transposons, DNA transposons, and endogenous retroviruses that can invade the human genome with a substantial contribution in human evolution and genomic diversity. TEs are therefore firmly regulated from early embryonic development and during the entire course of human life by epigenetic mechanisms, in particular DNA methylation and histone modifications. The deregulation of TEs has been reported in some developmental diseases, as well as for different types of human cancers. To date, the role of TEs, the mechanisms underlying TE reactivation, and the interplay with DNA methylation in human cancers remain largely unexplained. We reviewed the loss of epigenetic regulation and subsequent genomic instability, chromosomal aberrations, transcriptional deregulation, oncogenic activation, and aberrations of non-coding RNAs as the potential mechanisms underlying TE deregulation in human cancers.
- Published
- 2017
- Full Text
- View/download PDF
7. Serum leptin, C-reactive protein, and cancer mortality in the NHANES III.
- Author
-
Wulaningsih W, Holmberg L, Ng T, Rohrmann S, and Van Hemelrijck M
- Subjects
- Female, History, 20th Century, Humans, Male, Neoplasms history, Population Surveillance, Proportional Hazards Models, Risk Factors, United States epidemiology, United States ethnology, C-Reactive Protein, Leptin blood, Neoplasms blood, Neoplasms mortality
- Abstract
Adipokines, such as leptin, may affect cancer through its link with inflammation and obesity. We investigated the association between leptin, C-reactive protein, and risk of cancer death while accounting general and abdominal obesity. From the Third National Health and Examination Survey (NHANES III), we selected 5957 adult men and women with baseline measurements of serum leptin and CRP. Multivariable Cox regression was used to assess leptin and CRP levels (low, moderate, high) in relation to risk of cancer death. Stratification analyses were performed for obesity as defined by body mass index (BMI) and waist circumference. Fine and Gray regression was performed to account for death from cardiovascular disease and other causes as competing events. A total of 385 participants died of cancer during a mean follow-up of 18 years. After adjusting for BMI and waist circumference, an inverse association with log-transformed leptin was found for women, with a hazard ratio (HR) of 0.81 (95% confidence interval [CI]: 0.51-1.30) and 0.40 (95% CI: 0.24-0.68) for moderate and high compared to low levels of leptin, respectively; P(trend) = 0.0007). No association for leptin was observed in men, but higher CRP corresponded to increased risk of dying from cancer (HR: 2.98; 95% CI: 1.57-5.64 for the highest vs. lowest categories of CRP). Similar associations were observed with competing risk analysis also adjusted for BMI and waist circumference. Contrasting associations of serum leptin and CRP with cancer mortality may indicate sex-specific biological or environmental pathways linking obesity and cancer in men and women which warrant mechanistic investigations., (© 2015 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.)
- Published
- 2016
- Full Text
- View/download PDF
8. Serum lactate dehydrogenase and survival following cancer diagnosis.
- Author
-
Wulaningsih W, Holmberg L, Garmo H, Malmstrom H, Lambe M, Hammar N, Walldius G, Jungner I, Ng T, and Van Hemelrijck M
- Subjects
- Aged, Female, Humans, Male, Middle Aged, Neoplasms diagnosis, L-Lactate Dehydrogenase blood, Neoplasms blood, Neoplasms mortality
- Abstract
Background: There is evidence that high level of serum lactate dehydrogenase (LDH) is associated with poorer overall survival in several malignancies, but its link to cancer-specific survival is unclear., Methods: A total of 7895 individuals diagnosed with cancer between 1986 and 1999 were selected for this study. Multivariable Cox proportional hazards regression was used to assess overall and cancer-specific death by the z-score and clinical categories of serum LDH prospectively collected within 3 years before diagnosis. Site-specific analysis was performed for major cancers. Analysis was repeated by different lag times between LDH measurements and diagnosis., Results: At the end of follow-up, 5799 participants were deceased. Hazard ratios (HRs) and 95% confidence intervals (CIs) for overall and cancer-specific death in the multivariable model were 1.43 (1.31-1.56) and 1.46 (1.32-1.61), respectively, for high compared with low prediagnostic LDH. Site-specific analysis showed high LDH to correlate with an increased risk of death from prostate, pulmonary, colorectal, gastro-oesophageal, gynaecological and haematological cancers. Serum LDH assessed within intervals closer to diagnosis was more strongly associated with overall and cancer-specific death., Conclusions: Our findings demonstrated an inverse association of baseline serum LDH with cancer-specific survival, corroborating its role in cancer progression.
- Published
- 2015
- Full Text
- View/download PDF
9. Iron metabolism and risk of cancer in the Swedish AMORIS study.
- Author
-
Gaur A, Collins H, Wulaningsih W, Holmberg L, Garmo H, Hammar N, Walldius G, Jungner I, and Van Hemelrijck M
- Subjects
- Adult, C-Reactive Protein metabolism, Cohort Studies, Female, Humans, Inflammation metabolism, Male, Middle Aged, Multivariate Analysis, Neoplasms metabolism, Prospective Studies, Risk, Iron metabolism, Neoplasms epidemiology
- Abstract
Objectives: Pre-clinical studies have shown that iron can be carcinogenic, but few population-based studies investigated the association between markers of the iron metabolism and risk of cancer while taking into account inflammation. We assessed the link between serum iron (SI), total-iron binding capacity (TIBC), and risk of cancer by levels of C-reactive protein (CRP) in a large population-based study (n = 220,642)., Methods: From the Swedish Apolipoprotein Mortality Risk (AMORIS) study, we selected all participants (>20 years old) with baseline measurements of serum SI, TIBC, and CRP. Multivariate Cox proportional hazards regression was carried out for standardized and quartile values of SI and TIBC. Similar analyses were performed for specific cancers (pancreatic, colon, liver, respiratory, kidney, prostate, stomach, and breast cancer). To avoid reverse causation, we excluded those with follow-up <3 years., Results: We found a positive association between standardized TIBC and overall cancer [HR 1.03 (95% CI 1.01-1.05)]. No statistically significant association was found between SI and cancer risk except for postmenopausal breast cancer [HR for standardized SI 1.09 (95% CI 1.02-1.15)]. The association between TIBC and specific cancer was only statistically significant for colon cancer [i.e., HR for standardized TIBC: 1.17 (95% CI 1.08-1.28)]. A borderline interaction between SI and levels of CRP was observed only in stomach cancer., Conclusions: As opposed to pre-clinical findings for serum iron and cancer, this population-based epidemiological study showed an inverse relation between iron metabolism and cancer risk. Minimal role of inflammatory markers observed warrants further study focusing on developments of specific cancers.
- Published
- 2013
- Full Text
- View/download PDF
10. Inorganic phosphate and the risk of cancer in the Swedish AMORIS study.
- Author
-
Wulaningsih W, Michaelsson K, Garmo H, Hammar N, Jungner I, Walldius G, Holmberg L, and Van Hemelrijck M
- Subjects
- Adult, Cohort Studies, Female, Humans, Male, Middle Aged, Proportional Hazards Models, Risk Factors, Sweden epidemiology, Neoplasms blood, Neoplasms epidemiology, Phosphates blood
- Abstract
Background: Both dietary and serum levels of inorganic phosphate (Pi) have been linked to development of cancer in experimental studies. This is the first population-based study investigating the relation between serum Pi and risk of cancer in humans., Methods: From the Swedish Apolipoprotein Mortality Risk (AMORIS) study, we selected all participants (> 20 years old) with baseline measurements of serum Pi, calcium, alkaline phosphatase, glucose, and creatinine (n = 397,292). Multivariable Cox proportional hazards regression analyses were used to assess serum Pi in relation to overall cancer risk. Similar analyses were performed for specific cancer sites., Results: We found a higher overall cancer risk with increasing Pi levels in men ( HR: 1.02 (95% CI: 1.00-1.04) for every SD increase in Pi), and a negative association in women (HR: 0.97 (95% CI: 0.96-0.99) for every SD increase in Pi). Further analyses for specific cancer sites showed a positive link between Pi quartiles and the risk of cancer of the pancreas, lung, thyroid gland and bone in men, and cancer of the oesophagus, lung, and nonmelanoma skin cancer in women. Conversely, the risks for developing breast and endometrial cancer as well as other endocrine cancer in both men and women were lower in those with higher Pi levels., Conclusions: Abnormal Pi levels are related to development of cancer. Furthermore, the in verse association between Pi levels and risk of breast, endometrial and other endocrine cancers may indicate the role of hormonal factors in the relation between Pi metabolism and cancer.
- Published
- 2013
- Full Text
- View/download PDF
11. Serum glucose and fructosamine in relation to risk of cancer.
- Author
-
Wulaningsih W, Holmberg L, Garmo H, Zethelius B, Wigertz A, Carroll P, Lambe M, Hammar N, Walldius G, Jungner I, and Van Hemelrijck M
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Neoplasms epidemiology, Proportional Hazards Models, Risk Factors, Sweden epidemiology, Young Adult, Blood Glucose, Fructosamine blood, Neoplasms blood
- Abstract
Background: Impaired glucose metabolism has been linked with increased cancer risk, but the association between serum glucose and cancer risk remains unclear. We used repeated measurements of glucose and fructosamine to get more insight into the association between the glucose metabolism and risk of cancer., Methods: We selected 11,998 persons (>20 years old) with four prospectively collected serum glucose and fructosamine measurements from the Apolipoprotein Mortality Risk (AMORIS) study. Multivariate Cox proportional hazards regression was used to assess standardized log of overall mean glucose and fructosamine in relation to cancer risk. Similar analyses were performed for tertiles of glucose and fructosamine and for different types of cancer., Results: A positive trend was observed between standardized log overall mean glucose and overall cancer risk (HR= 1.08; 95% CI: 1.02-1.14). Including standardized log fructosamine in the model resulted in a stronger association between glucose and cancer risk and aninverse association between fructosamine and cancer risk (HR = 1.17; 95% CI: 1.08-1.26 and HR: 0.89; 95% CI: 0.82-0.96, respectively). Cancer risks were highest among those in the highest tertile of glucose and lowest tertile of fructosamine. Similar findings were observed for prostate, lung, and colorectal cancer while none observed for breast cancer., Conclusion: The contrasting effect between glucose, fructosamine, and cancer risk suggests the existence of distinct groups among those with impaired glucose metabolism, resulting in different cancer risks based on individual metabolic profiles. Further studies are needed to clarify whether glucose is a proxy of other lifestyle-related or metabolic factors.
- Published
- 2013
- Full Text
- View/download PDF
12. Serum leptin, C-reactive protein, and cancer mortality in the NHANES III
- Author
-
Tony Ng, Wahyu Wulaningsih, Lars Holmberg, Mieke Van Hemelrijck, Sabine Rohrmann, University of Zurich, and Wulaningsih, Wahyu
- Subjects
Leptin ,Male ,0301 basic medicine ,Cancer Research ,Gastroenterology ,0302 clinical medicine ,Risk Factors ,Neoplasms ,1306 Cancer Research ,Abdominal obesity ,Original Research ,Cancer ,Hazard ratio ,C‐reactive protein ,C-Reactive Protein ,Oncology ,Population Surveillance ,030220 oncology & carcinogenesis ,Female ,2730 Oncology ,medicine.symptom ,Cancer Prevention ,prospective study ,medicine.medical_specialty ,Waist ,Adipokine ,610 Medicine & health ,leptin ,C-reactive protein ,03 medical and health sciences ,Internal medicine ,medicine ,Humans ,2741 Radiology, Nuclear Medicine and Imaging ,Radiology, Nuclear Medicine and imaging ,Proportional Hazards Models ,Cancer och onkologi ,business.industry ,10060 Epidemiology, Biostatistics and Prevention Institute (EBPI) ,History, 20th Century ,medicine.disease ,Obesity ,mortality ,United States ,030104 developmental biology ,Endocrinology ,Cancer and Oncology ,business ,Body mass index - Abstract
Adipokines, such as leptin, may affect cancer through its link with inflammation and obesity. We investigated the association between leptin, C‐reactive protein, and risk of cancer death while accounting general and abdominal obesity. From the Third National Health and Examination Survey (NHANES III), we selected 5957 adult men and women with baseline measurements of serum leptin and CRP. Multivariable Cox regression was used to assess leptin and CRP levels (low, moderate, high) in relation to risk of cancer death. Stratification analyses were performed for obesity as defined by body mass index (BMI) and waist circumference. Fine and Gray regression was performed to account for death from cardiovascular disease and other causes as competing events. A total of 385 participants died of cancer during a mean follow‐up of 18 years. After adjusting for BMI and waist circumference, an inverse association with log‐transformed leptin was found for women, with a hazard ratio (HR) of 0.81 (95% confidence interval [CI]: 0.51–1.30) and 0.40 (95% CI: 0.24–0.68) for moderate and high compared to low levels of leptin, respectively; P trend = 0.0007). No association for leptin was observed in men, but higher CRP corresponded to increased risk of dying from cancer (HR: 2.98; 95% CI: 1.57–5.64 for the highest vs. lowest categories of CRP). Similar associations were observed with competing risk analysis also adjusted for BMI and waist circumference. Contrasting associations of serum leptin and CRP with cancer mortality may indicate sex‐specific biological or environmental pathways linking obesity and cancer in men and women which warrant mechanistic investigations.
- Published
- 2016
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.